Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hungarian Multicenter Non-Interventional Study of Continued Avastin (Bevacizumab) Plus Chemotherapy Until First Progression Following Induction Treatment With Chemotherapy Doublet Plus Avastin in First Line Treatment of Patients With Metastatic Colorectal Carcinoma

NCT02305615 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT02305615
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02305615 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hungarian Multicenter Non-Interventional Study of Continued Avastin (Bevacizumab) Plus Chemotherapy Until First Progression Following Induction Treatment With Chemotherapy Doublet Plus Avastin in First Line Treatment of Patients With Metastatic Colorectal Carcinoma
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
January 13, 2015
Completion date
December 29, 2017
Enrollment
300 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer